Kesimpta (ofatumumab) can cause allergic reactions, although such events are relatively uncommon. Allergic reactions to Kesimpta may range from mild to severe, including symptoms like rash, itching, swelling, and in rare cases, anaphylaxis, which is a serious, potentially life-threatening allergic…
Kesimpta, known generically as ofatumumab, is a medication used primarily to treat multiple sclerosis (MS), an autoimmune disease where the immune system mistakenly attacks the nervous system. Because Kesimpta works by targeting and reducing certain immune cells (specifically B-cells), it…
Kesimpta is a medication used primarily to treat relapsing forms of multiple sclerosis (MS). It works by targeting specific immune cells to reduce inflammation and slow disease progression. Like many medications, Kesimpta can cause side effects, which range from mild…
Mavenclad (cladribine) is a medication used primarily to treat relapsing forms of multiple sclerosis (MS). It works by selectively reducing certain immune cells, particularly lymphocytes, which play a key role in the autoimmune attack on the nervous system seen in…
Mavenclad (cladribine) is **not considered safe during pregnancy** due to its potential to cause serious fetal harm. It is explicitly contraindicated for use in pregnant women and in women and men of reproductive potential who do not plan to use…
Mavenclad, whose active ingredient is cladribine, offers several significant benefits for people with relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS and active secondary progressive MS. It is an oral medication designed to reduce the frequency of MS relapses…
Mavenclad, whose active ingredient is cladribine, is a medication primarily used to treat multiple sclerosis (MS), a chronic autoimmune disease where the immune system mistakenly attacks the nervous system. One of the key questions many patients and healthcare providers have…
Mavenclad, a medication used to treat certain forms of multiple sclerosis (MS), can cause hair loss, but this side effect is relatively uncommon and usually not severe. Hair loss occurs in about 3% of people taking Mavenclad, making it an…
Mavenclad, whose active ingredient is cladribine, is a medication primarily used to treat relapsing forms of multiple sclerosis (MS). It works by selectively targeting certain immune cells, particularly lymphocytes, which play a role in the autoimmune process that damages nerve…
Mavenclad, whose active ingredient is cladribine, is a medication used primarily to treat relapsing-remitting multiple sclerosis (RRMS). While it can be effective in reducing the frequency of relapses and slowing disability progression, it also comes with a range of potential…